| Patents for C12P 21 - Preparation of peptides or proteins (112,499) | 
|---|
| 05/16/2012 | CN1968712B Novel antigen-binding polypeptides and their uses  | 
| 05/16/2012 | CN1863556B Compositions and methods for treating coagulation related disorders  | 
| 05/16/2012 | CN1842600B A process for proteolytic cleavage and purification of recombinant proteins  | 
| 05/16/2012 | CN102459628A Anti-human cd52 immunoglobulins  | 
| 05/16/2012 | CN102459627A 通过酰基-辅酶A溶血磷脂酰基转移酶的表达对长链ω-3和ω-6多不饱和脂肪酸的生物合成的改善 By acyl - coenzyme A lysophospholipid acyltransferase expression of long-chain ω-3 and ω-6 redundant creature improved synthesis of unsaturated fatty acids  | 
| 05/16/2012 | CN102459608A 组合工程 Integrated Engineering  | 
| 05/16/2012 | CN102459603A Fucosylation-deficient cells  | 
| 05/16/2012 | CN102459586A Expression vector for establishing hyper-producing cells, and hyper-producing cells  | 
| 05/16/2012 | CN102459570A Zymomonas with improved arabinose utilization  | 
| 05/16/2012 | CN102459346A Method for making heteromultimeric molecules  | 
| 05/16/2012 | CN102459342A Anti-il-3ra antibody for use in treatment of blood tumor  | 
| 05/16/2012 | CN102459317A 用于crm197及其衍生物的生产的人工基因的细菌表达 Crm197 bacterial expression and its derivatives for the production of artificial genes  | 
| 05/16/2012 | CN102458617A 层叠的转基因蛋白质的多重分析 Multi-layered analysis of transgenic protein  | 
| 05/16/2012 | CN102458469A Stable high protein concentration formulations of human anti-tnf-alpha-antibodies  | 
| 05/16/2012 | CN102458468A Anti-cd100 antibodies and methods for using the same  | 
| 05/16/2012 | CN102458459A 双重可变结构域免疫球蛋白及其用途 Dual variable domain immunoglobulins and their use  | 
| 05/16/2012 | CN102453741A Method for preparing high-activity corn antihypertensive peptide and special device  | 
| 05/16/2012 | CN102453711A Establishment of protein secreted expression vector and application of same  | 
| 05/16/2012 | CN102453108A Combined production method for processing chondroitin sulfate and protein powder with bird skeletons as raw material  | 
| 05/16/2012 | CN102453077A Novel fluoronosiheptide and preparation method and application thereof  | 
| 05/16/2012 | CN101899410B Streptomyces parvus and application thereof for preparing daptomycin  | 
| 05/16/2012 | CN101696243B Human genetic engineering antibody TRD 109 as well as preparation method and application thereof  | 
| 05/16/2012 | CN101306019B Hyper-concentrated placenta nano viable cell freeze-drying capsules and its preparation method  | 
| 05/16/2012 | CN101255431B Corynebacterium glutamicum genes encoding metabolic pathway proteins  | 
| 05/15/2012 | US8178346 GPCR expression vector  | 
| 05/15/2012 | US8178339 Reduced genome E. coli  | 
| 05/15/2012 | US8178337 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor  | 
| 05/15/2012 | US8178336 Polypeptide  | 
| 05/15/2012 | US8178335 Intracellular production of a nuclease  | 
| 05/15/2012 | US8178328 Fermentive production of four carbon alcohols  | 
| 05/15/2012 | US8178324 Deracemisation of amines  | 
| 05/15/2012 | US8178320 Artificial antibody library with super-repertory  | 
| 05/15/2012 | US8178319 Peptides and uses thereof  | 
| 05/15/2012 | US8178318 Method for controlling pH, osmolality and dissolved carbon dioxide levels in a mammalian cell culture process to enhance cell viability and biologic product yield  | 
| 05/15/2012 | US8178317 Compositions and methods for identifying transforming and tumor suppressor genes  | 
| 05/15/2012 | US8178316 Evaluating proteins  | 
| 05/15/2012 | US8178310 Babesia microti genomic clones containing novel antigens useful in the diagnosis of Babesios  | 
| 05/15/2012 | US8178298 Patched polypeptides and uses related thereto  | 
| 05/15/2012 | US8178101 Use of anti-IL-6 antibodies having specific binding properties to treat cachexia  | 
| 05/15/2012 | US8178093 Method for treating infectious disease using monoclonal antibodies  | 
| 05/15/2012 | US8178082 Methods for up-regulating PAP1 in animals suffering from pancreatic disorders  | 
| 05/15/2012 | CA2681922C Zinc finger protein derivatives and methods therefor  | 
| 05/15/2012 | CA2505705C Compositions and methods for the diagnosis and treatment of tumor  | 
| 05/15/2012 | CA2465891C Recombinant antibodies for the detection and neutralization of anthrax toxin  | 
| 05/15/2012 | CA2450476C A soluble complex comprising a retroviral surface glycoprotein  | 
| 05/15/2012 | CA2439452C High-affinity antagonists of elr-cxc chemokines  | 
| 05/15/2012 | CA2434237C Glp-1 fusion proteins  | 
| 05/15/2012 | CA2409940C Anti-listeria bacteriocin  | 
| 05/15/2012 | CA2335098C Protease susceptibility ii  | 
| 05/15/2012 | CA2272842C Humanized anti-cd11a antibodies  | 
| 05/10/2012 | WO2012061776A1 Methods for producing virus particles with simplified glycosylation of surface proteins  | 
| 05/10/2012 | WO2012061637A2 Hsv-1 epitopes and methods for using same  | 
| 05/10/2012 | WO2012059715A1 Expression process  | 
| 05/10/2012 | WO2012026309A9 Creation of anti-pad4 antibody pharmaceutical  | 
| 05/10/2012 | WO2012018767A3 Antibodies directed against il-17  | 
| 05/10/2012 | US20120117670 Humanized axl antibodies  | 
| 05/10/2012 | US20120117669 Human antibodies derived from immunized xenomice  | 
| 05/10/2012 | US20120116057 Design of stable and aggregation free antibody fc molecules through ch3 domain interface engineering  | 
| 05/10/2012 | US20120116056 Fc fusion proteins of human growth hormone  | 
| 05/10/2012 | US20120116053 Expression of triple-helical collagen-like products in e.coli  | 
| 05/10/2012 | US20120116052 Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 Domain  | 
| 05/10/2012 | US20120115775 Mutant tat proteins and uses thereof  | 
| 05/10/2012 | US20120115741 Reagents For The Atherosclerotic Coronary Plaque And Uses Thereof  | 
| 05/10/2012 | US20120115233 Leafhopper Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof  | 
| 05/10/2012 | US20120115187 Production Of Recombinant Proteins Utilizing Non-Antibiotic Selection Methods And The Incorporation Of Non-Natural Amino Acids Therein  | 
| 05/10/2012 | US20120115156 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use  | 
| 05/10/2012 | US20120115151 Method for testing a subject thought to be predisposed to having metastatic cancer using delta133p53beta  | 
| 05/10/2012 | US20120114797 Talaromyces strains and enzyme compositions  | 
| 05/10/2012 | US20120114776 Methods for preparing probiotic nanoparticles  | 
| 05/10/2012 | US20120114708 Integrin heterodimer and an alpha subunit thereof  | 
| 05/10/2012 | US20120114686 Compositions and methods related to protein a (spa) variants  | 
| 05/10/2012 | US20120114672 Antibodies Specific to Cadherin-17  | 
| 05/10/2012 | US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF  | 
| 05/10/2012 | US20120114665 Human antibodies to human rankl  | 
| 05/10/2012 | US20120114660 Antibodies Against LLG Polypeptides of the Triacylglycerol Lipase Family  | 
| 05/10/2012 | US20120114659 Antibodies for Guanylyl Cyclase Receptors  | 
| 05/10/2012 | US20120114657 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of Serotype IATS 01 of Pseudomonas Aeruginosa  | 
| 05/10/2012 | US20120114654 Human antibodies to human tnf-like ligand 1a (tl1a)  | 
| 05/10/2012 | US20120114652 Anti-pai-1 antibodies and methods of use thereof  | 
| 05/10/2012 | US20120114650 Single chain antibodies against beta-amyloid peptide  | 
| 05/10/2012 | US20120114630 Variants of plasminogen and plasmin  | 
| 05/10/2012 | US20120114613 Definitive endoderm cell populations  | 
| 05/10/2012 | US20120114603 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities  | 
| 05/10/2012 | CA2854619A1 Methods for producing virus particles with simplified glycosylation of surface proteins  | 
| 05/09/2012 | EP2450364A1 Process for production of peptide thioester  | 
| 05/09/2012 | EP2450056A1 Prevention and treatment of synucleinopathic and amyloidogenic disease  | 
| 05/09/2012 | EP2449127A2 Polypeptides and method of treatment  | 
| 05/09/2012 | EP2449126A1 Novel antibodies and their uses in therapeutic and diagnostic methods  | 
| 05/09/2012 | EP2449101A1 Neurotoxins exhibiting shortened biological activity  | 
| 05/09/2012 | EP2449098A1 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes  | 
| 05/09/2012 | EP2267024B1 Production of recombinant Il-18 binding protein  | 
| 05/09/2012 | EP1733041B1 Anti-myostatin antibodies  | 
| 05/09/2012 | EP1660686B1 Hpv cd8+ t-cell epitopes  | 
| 05/09/2012 | EP1496110B1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes  | 
| 05/09/2012 | CN102449160A Process for production of useful substance, and surfactant for use in the process  | 
| 05/09/2012 | CN102448494A Immunoconjugates with an intracellularly-cleavable linkage  | 
| 05/09/2012 | CN102448486A Antibody drug conjugates (ADC) that bind to 24p4c12 proteins  | 
| 05/09/2012 | CN102443618A Method for generating polypeptide by enzymolysis of oyster extract  | 
| 05/09/2012 | CN102443617A Preparation method for garlic blood pressure-lowering functional factor through ultrasound-assisted enzymatic hydrolysis  | 
| 05/09/2012 | CN102443594A Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application  |